GSK-729
CAS No. 1260243-45-5
GSK-729 ( GSK 729;GSK729 )
Catalog No. M11073 CAS No. 1260243-45-5
A potent, small molecule inhibitor of Mycobacterium tuberculosis enoyl-coenzyme A (CoA) hydratase EchA6 with IC50 of 1.8 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
|
50MG | 1782 | Get Quote |
|
100MG | 2250 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK-729
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, small molecule inhibitor of Mycobacterium tuberculosis enoyl-coenzyme A (CoA) hydratase EchA6 with IC50 of 1.8 uM.
-
DescriptionA potent, small molecule inhibitor of Mycobacterium tuberculosis enoyl-coenzyme A (CoA) hydratase EchA6 with IC50 of 1.8 uM, but not the MmpL3; selectively pulls down EchA6 in a stereospecific manner in M. bovis BCG extracts, competes with CoA-binding, suppresses mycolic acid synthesis, and are bactericidal in mouse model of chronic tuberculosis infection.
-
SynonymsGSK 729;GSK729
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1260243-45-5
-
Formula Weight339.32
-
Molecular FormulaC16H16F3N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C1=C2N[C@H](C3=CC=C(CC)C=C3)C[C@H](C(F)(F)F)N2N=C1)O
-
Chemical Name(5R,7S)-5-(4-ethylphenyl)-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cox JA, et al. Nat Microbiol. 2016 Jan 18;1:15006.
molnova catalog
related products
-
Iclaprim
Iclaprim is a novel specific bacterial Dihydrofolate inhibitor.
-
medicagenic acid
Medicagenic acid (Castanogenin) isolated from the roots of Herniaria glabra L exhibits potent fungistatic effects against several plant pathogens and human dermatophytes.
-
Moxifloxacin hydroch...
A fourth-generation synthetic fluoroquinolone, broad-spectrum antibacterial agent that is active against both Gram-positive and Gram-negative bacteria.